Skip to main content
PMC home page
Molecular Pathology : MP logoLink to Molecular Pathology : MP
. 1997 Jun;50(3):138–144. doi: 10.1136/mp.50.3.138

Expression of the Wilms' tumour gene WT1 in the developing human and in paediatric renal tumours: an immunohistochemical study.

A K Charles 1, S Mall 1, J Watson 1, P J Berry 1
PMCID: PMC379608  PMID: 9292148

Abstract

AIMS: The Wilms' tumour gene (WT1) product is expressed during the development of the urogenital system. This study was undertaken to evaluate four anti-WT1 antibodies and use the most specific one to examine the expression of WT1 in formalin fixed, paraffin wax embedded tissues from human embryos, fetuses, and paediatric renal neoplasms. METHODS: The antibodies were assessed on paraffin sections of fetal kidney and by western blotting. Immunohistochemical techniques were optimised and performed on a range of embryonic, fetal, and infant tissues from 35 days post-conception to three months of age, and on a selection of paediatric renal neoplasms. RESULTS: The antibodies tested were found to vary in their specificity. Anomalous expression in smooth muscle was seen with one batch of a commercial polyclonal antibody. WT1 protein was detected in both the metanephros and the mesonephros, the spleen, the gonads, and in the peritoneal mesothelium in fetuses. WT1 was expressed in nuclei and was strongest in the podocytes of fetal kidney. The podocytes of infant glomeruli were also positive. There was focal positive staining in Wilms' tumours, nephrogenic rests, and in a cystic partially differentiated nephroblastoma. Staining of nuclei was seen in one of two rhabdoid tumours of the kidney. No positive staining was seen in other renal tumours. CONCLUSIONS: WT1 is detected readily in formalin fixed material. There were differences in specificity between batches of the polyclonal antibodies used. The distribution of the WT1 gene product in tissues and tumours reflected previous findings with in situ hybridisation studies of WT1 mRNA.

Full text

PDF
138

Images in this article

140Image
on p.140
141Image
on p.141

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bard J. B., McConnell J. E., Davies J. A. Towards a genetic basis for kidney development. Mech Dev. 1994 Oct;48(1):3–11. doi: 10.1016/0925-4773(94)00273-8. [DOI] [PubMed] [Google Scholar]
  2. Beckwith J. B., Kiviat N. B., Bonadio J. F. Nephrogenic rests, nephroblastomatosis, and the pathogenesis of Wilms' tumor. Pediatr Pathol. 1990;10(1-2):1–36. doi: 10.3109/15513819009067094. [DOI] [PubMed] [Google Scholar]
  3. Breslow N. E., Olson J., Moksness J., Beckwith J. B., Grundy P. Familial Wilms' tumor: a descriptive study. Med Pediatr Oncol. 1996 Nov;27(5):398–403. doi: 10.1002/(SICI)1096-911X(199611)27:5<398::AID-MPO2>3.0.CO;2-H. [DOI] [PubMed] [Google Scholar]
  4. Brown K. W., Wilmore H. P., Watson J. E., Mott M. G., Berry P. J., Maitland N. J. Low frequency of mutations in the WT1 coding region in Wilms' tumor. Genes Chromosomes Cancer. 1993 Oct;8(2):74–79. doi: 10.1002/gcc.2870080203. [DOI] [PubMed] [Google Scholar]
  5. Charles A. K., Moore I. E., Berry P. J. Immunohistochemical detection of the Wilms' tumour gene WT1 in desmoplastic small round cell tumour. Histopathology. 1997 Apr;30(4):312–314. doi: 10.1046/j.1365-2559.1997.d01-620.x. [DOI] [PubMed] [Google Scholar]
  6. Coppes M. J., Bonetta L., Huang A., Hoban P., Chilton-MacNeill S., Campbell C. E., Weksberg R., Yeger H., Reeve A. E., Williams B. R. Loss of heterozygosity mapping in Wilms tumor indicates the involvement of three distinct regions and a limited role for nondisjunction or mitotic recombination. Genes Chromosomes Cancer. 1992 Nov;5(4):326–334. doi: 10.1002/gcc.2870050408. [DOI] [PubMed] [Google Scholar]
  7. Francke U., Holmes L. B., Atkins L., Riccardi V. M. Aniridia-Wilms' tumor association: evidence for specific deletion of 11p13. Cytogenet Cell Genet. 1979;24(3):185–192. doi: 10.1159/000131375. [DOI] [PubMed] [Google Scholar]
  8. Gaddy C. D., Gibbons M. D., Gonzales E. T., Jr, Finegold M. J. Obstructive uropathy, renal dysplasia and nodular renal blastema: is there a relationship to Wilms tumor? J Urol. 1985 Aug;134(2):330–333. doi: 10.1016/s0022-5347(17)47154-0. [DOI] [PubMed] [Google Scholar]
  9. Goodyer P., Dehbi M., Torban E., Bruening W., Pelletier J. Repression of the retinoic acid receptor-alpha gene by the Wilms' tumor suppressor gene product, wt1. Oncogene. 1995 Mar 16;10(6):1125–1129. [PubMed] [Google Scholar]
  10. Grundy P. E., Telzerow P. E., Breslow N., Moksness J., Huff V., Paterson M. C. Loss of heterozygosity for chromosomes 16q and 1p in Wilms' tumors predicts an adverse outcome. Cancer Res. 1994 May 1;54(9):2331–2333. [PubMed] [Google Scholar]
  11. Haber D. A., Buckler A. J., Glaser T., Call K. M., Pelletier J., Sohn R. L., Douglass E. C., Housman D. E. An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms' tumor. Cell. 1990 Jun 29;61(7):1257–1269. doi: 10.1016/0092-8674(90)90690-g. [DOI] [PubMed] [Google Scholar]
  12. Huang A., Campbell C. E., Bonetta L., McAndrews-Hill M. S., Chilton-MacNeill S., Coppes M. J., Law D. J., Feinberg A. P., Yeger H., Williams B. R. Tissue, developmental, and tumor-specific expression of divergent transcripts in Wilms tumor. Science. 1990 Nov 16;250(4983):991–994. doi: 10.1126/science.2173145. [DOI] [PubMed] [Google Scholar]
  13. Kent J., Coriat A. M., Sharpe P. T., Hastie N. D., van Heyningen V. The evolution of WT1 sequence and expression pattern in the vertebrates. Oncogene. 1995 Nov 2;11(9):1781–1792. [PubMed] [Google Scholar]
  14. Kreidberg J. A., Sariola H., Loring J. M., Maeda M., Pelletier J., Housman D., Jaenisch R. WT-1 is required for early kidney development. Cell. 1993 Aug 27;74(4):679–691. doi: 10.1016/0092-8674(93)90515-r. [DOI] [PubMed] [Google Scholar]
  15. Larsson S. H., Charlieu J. P., Miyagawa K., Engelkamp D., Rassoulzadegan M., Ross A., Cuzin F., van Heyningen V., Hastie N. D. Subnuclear localization of WT1 in splicing or transcription factor domains is regulated by alternative splicing. Cell. 1995 May 5;81(3):391–401. doi: 10.1016/0092-8674(95)90392-5. [DOI] [PubMed] [Google Scholar]
  16. Maheswaran S., Park S., Bernard A., Morris J. F., Rauscher F. J., 3rd, Hill D. E., Haber D. A. Physical and functional interaction between WT1 and p53 proteins. Proc Natl Acad Sci U S A. 1993 Jun 1;90(11):5100–5104. doi: 10.1073/pnas.90.11.5100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Malik K. T., Poirier V., Ivins S. M., Brown K. W. Autoregulation of the human WT1 gene promoter. FEBS Lett. 1994 Jul 25;349(1):75–78. doi: 10.1016/0014-5793(94)00642-3. [DOI] [PubMed] [Google Scholar]
  18. Pelletier J., Schalling M., Buckler A. J., Rogers A., Haber D. A., Housman D. Expression of the Wilms' tumor gene WT1 in the murine urogenital system. Genes Dev. 1991 Aug;5(8):1345–1356. doi: 10.1101/gad.5.8.1345. [DOI] [PubMed] [Google Scholar]
  19. Pritchard-Jones K., Fleming S. Cell types expressing the Wilms' tumour gene (WT1) in Wilms' tumours: implications for tumour histogenesis. Oncogene. 1991 Dec;6(12):2211–2220. [PubMed] [Google Scholar]
  20. Pritchard-Jones K., Fleming S., Davidson D., Bickmore W., Porteous D., Gosden C., Bard J., Buckler A., Pelletier J., Housman D. The candidate Wilms' tumour gene is involved in genitourinary development. Nature. 1990 Jul 12;346(6280):194–197. doi: 10.1038/346194a0. [DOI] [PubMed] [Google Scholar]
  21. Ramani P., Cowell J. K. The expression pattern of Wilms' tumour gene (WT1) product in normal tissues and paediatric renal tumours. J Pathol. 1996 Jun;179(2):162–168. doi: 10.1002/(SICI)1096-9896(199606)179:2<162::AID-PATH545>3.0.CO;2-0. [DOI] [PubMed] [Google Scholar]
  22. Sharifah N. A., Yun K. Malignant rhabdoid tumor of the kidney expresses insulin-like growth factor II transcripts. Pathology. 1994 Apr;26(2):134–137. doi: 10.1080/00313029400169361. [DOI] [PubMed] [Google Scholar]
  23. Wang Z. Y., Qiu Q. Q., Gurrieri M., Huang J., Deuel T. F. WT1, the Wilms' tumor suppressor gene product, represses transcription through an interactive nuclear protein. Oncogene. 1995 Mar 16;10(6):1243–1247. [PubMed] [Google Scholar]
  24. Weeks D. A., Beckwith J. B., Mierau G. W., Luckey D. W. Rhabdoid tumor of kidney. A report of 111 cases from the National Wilms' Tumor Study Pathology Center. Am J Surg Pathol. 1989 Jun;13(6):439–458. [PubMed] [Google Scholar]
  25. Wilmore H. P., White G. F., Howell R. T., Brown K. W. Germline and somatic abnormalities of chromosome 7 in Wilms' tumor. Cancer Genet Cytogenet. 1994 Oct 15;77(2):93–98. doi: 10.1016/0165-4608(94)90221-6. [DOI] [PubMed] [Google Scholar]

Articles from Molecular Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES